HRZN

Horizon Technology Finance Corp. (HRZN) - Q1 2020 Filing Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 2020. Horizon Technology Finance Corporation is an externally managed, closed-end, non-diversified management investment company regulated as a Business Development Company (BDC) and taxed as a Regulated Investment Company (RIC). The Company primarily makes secured debt investments to development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.

Key Financial Metrics

Material Changes vs. Prior Period

• Portfolio Valuation: The Company reported a significant net unrealized depreciation of $8.5 million, compared to $1.4 million in the prior year. This was primarily driven by unrealized depreciation on four debt investments and the reversal of previously recorded unrealized appreciation from warrant terminations.
• Investment Income: Total investment income increased 21.8% to $10.1 million, driven by a 31.9% increase in the average size of the debt investment portfolio, partially offset by lower LIBOR rates.
• Realized Gains: Net realized gains increased to $3.5 million, largely due to gains from the termination of warrants upon the sale of two portfolio companies.
• Liquidity: Cash and cash equivalents increased significantly to $38.8 million from $16.3 million, supported by proceeds from an At-The-Market (ATM) equity offering ($16.2 million) and increased borrowings on the Key Facility.
• Expense Structure: Net expenses increased to $5.8 million. Notably, the Advisor waived $1.1 million in performance-based incentive fees in Q1 2019, a non-recurring benefit not present in Q1 2020.

Outlook, Risks, and Management Commentary

• COVID-19 Impact: Management highlighted that the global spread of COVID-19 has caused increased market volatility and economic uncertainty, materially affecting portfolio valuations. The extent of future adverse financial and operational consequences remains uncertain.
• Asset Coverage: As of March 31, 2020, asset coverage for borrowed amounts was 206%, well above the 150% minimum requirement under the 1940 Act.
• Subsequent Events:
  • On April 9, 2020, HealthEdge Software, Inc. repaid its $13.1 million loan in full.
  • On April 21, 2020, the Company purchased Arena's 50% interest in the Horizon Secured Loan Fund I LLC (HSLFI) joint venture for $17.1 million, making HSLFI a wholly-owned subsidiary to be consolidated in future periods.
• Capital Markets: The Company maintains an active ATM program with approximately $9.0 million remaining available for issuance as of March 31, 2020. A stock repurchase program allowing up to $5.0 million of repurchases was extended in April 2020.

Key Facts for Investor Verification

• Unrealized Loss Drivers: Verify the specific portfolio companies contributing to the $8.5 million unrealized depreciation and the credit quality ratings of these assets.
• Non-Accrual Status: Confirm the status of the three debt investments on non-accrual status (cost of $12.8 million, fair value of $9.4 million) as of March 31, 2020.
• HSLFI Consolidation: Monitor the impact of the April 2020 acquisition of HSLFI on future consolidated financial statements and leverage ratios.
• Interest Rate Sensitivity: Assess the impact of potential further declines in LIBOR on net investment income, given that 100% of the debt portfolio bears floating rates.
• Distribution Coverage: Note that distributions declared ($0.35/share) exceeded net investment income ($0.26/share) for the quarter, indicating reliance on spillover income or return of capital to maintain the distribution rate.